US 10669544
Therapeutic compositions
granted A61KA61K31/713A61K47/554
Quick answer
US patent 10669544 (Therapeutic compositions) held by Alnylam Pharmaceuticals, Inc. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K47/554, A61P, A61P3/10